Wenzhuo Cheng
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Expression of IMD-CBM peptide induces the autophagic degradation of CAV1 (caveolin 1) to inhibit LDL transcytosis and retard diabetic atherosclerosis.
Journal: Autophagy
Published: February 13, 2026
KAP1 SUMOylates and stabilizes SR-A to facilitate glycated LDL transcytosis and accelerate atherosclerosis.
Journal: Cellular & molecular biology letters
Published: December 17, 2025
Chinese carrier of the HNF1A p.Gln444fs variant exhibits enhanced response to sulfonylureas.
Journal: Heliyon
Published: April 09, 2024
Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families.
Journal: World journal of surgical oncology
Published: October 21, 2023
AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE/NF-κB/Caveolin-1 pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: May 04, 2023
Editorial: Advances of endocrine and metabolic cardiovascular outcomes: From basic to clinical science, volume II.
Journal: Frontiers in endocrinology
Published: December 02, 2022
Remnant cholesterol is independently asssociated with an increased risk of peripheral artery disease in type 2 diabetic patients.
Journal: Frontiers in endocrinology
Published: November 29, 2022
Scavenger receptor a mediates glycated LDL transcytosis across endothelial cells to promote atherosclerosis.
Journal: International journal of biological macromolecules
Published: November 22, 2022
Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: A cross-sectional study.
Journal: Frontiers in endocrinology
Published: November 16, 2022
VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.
Journal: Metabolism: clinical and experimental
Published: February 24, 2022
Deacetylation of Caveolin-1 by Sirt6 induces autophagy and retards high glucose-stimulated LDL transcytosis and atherosclerosis formation.
Journal: Metabolism: clinical and experimental
Published: November 24, 2021
Age-related changes of human serum Sirtuin6 in adults.
Journal: BMC geriatrics
Published: March 16, 2021
Last Updated: 09/26/2026